Mental Help Net
ADHD: Attention Deficit Hyperactivity Disorder
Basic Information
Childhood ADHD OverviewADHD Discoveries and ControversiesCauses of ADHD in ChildrenADHD or Another Condition?Diagnosis of ADHD in ChildrenADHD Treatment in ChildrenFamily and Personal SupportsAdult ADHD OverviewDiagnosis of Adult ADHDAdult ADHD TreatmentADHD Resources and References
More InformationTestsLatest NewsQuestions and AnswersBlog EntriesVideosLinksBook Reviews
Therapist Search
Find a Therapist:
 (USA/CAN only)

Use our Advanced Search to locate a therapist outside of North America.

Related Topics

Bipolar Disorder
Child & Adolescent Development: Overview
Learning Disorders
View the Depression Primer - an illustrated book about Depression
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Mark Dombeck, Ph.D.Mark Dombeck, Ph.D.
Essays and Blogs Concerning Mental and Emotional Health

Daytrana skin patch for ADHD just approved

Mark Dombeck, Ph.D. Updated: Apr 8th 2006

The pharmaceutical company Shire has announced it has gained FDA approval for a new ADHD medication "patch" delivery mechanism. The new product, called Daytrana, is essentially the same old useful medication for ADHD, methylphenidate (aka amphetamine) that has been prescribed for ADHD for years and which is known to be effective. The thing that is new here is the delivery mechanism. Past ADHD stimulant formulations were delivered orally, in pill form. Unbuffered oral administration of any drug can lead to a spike in blood concentrations for that drug, typically followed by a falling off of drug levels as time goes on. Such unevenness of drug blood saturation across time could lead to inconsistant drug effects. Very large spikes in a stimulant drug such as is typically used for ADHD could also be used to get "high". While ADHD pills are buffered for time-release, they are still not perfect in this regard. The new skin-patch technology is essentially a push at making a better buffering technology for the medication. Daytrana is absorbed through the skin via a fabric patch which has been impregnated with the ADHD drug. The new technology apparently helps the drug get into the body in a more controled time-release fashion than what was possible before, which means that there is never a rush of stimulant, but instead, an even distribution of the drug across time. One would think also that a drug administered in patch form might be harder to abuse or resell too. Those darn kids are creative, however, and I won't be surprised if/when we soon hear about a black market in Daytrana patches ...

Mark Dombeck, Ph.D.

Mark Dombeck, Ph.D. was Director of Mental Help Net from 1999 to 2011. Presently, he is an Oakland Psychologist (Lic#PSY25695) in private practice offering evidence-based acceptance and commitment therapy (ACT) and cognitive behavioral therapy (CBT) and addressing a range of life problems. Contact Dr. Dombeck by calling 510-900-5123, send Dr. Dombeck email or visit Dr. Dombeck's practice website for more information.

Reader Comments
Discuss this issue below or in our forums.

Follow us on Twitter!

Find us on Facebook!

This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information:
verify here.

Powered by CenterSite.Net